Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
life sciences
national blog main
avapritinib
biotech
blueprint medicines
boston
boston top stories
national top stories
san francisco blog main
san francisco top stories
cancer
clinical trials
eli lilly
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
alex azar
alirocumab
american patients first
andrew berens
biosimilars
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
center for medicare and medicaid services
craig garthwaite
cstone pharmaceuticals
cvs health
deals
deciphera pharmaceuticals
department of health and human services
What
blueprint
4
×
drug
approval
cancer
fda
medicines
ret
address
afternoon
announced
anticipated
approves
awaited
candidate
carries
certain
chasing
cost
currently
cut
deadly
deciphera
designed
details
drugs
filing
forms
genetic
gi
house
latest
long
lower
marketing
meant
medicine
morning
muscle
pact
pass
Language
unset
Current search:
blueprint
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details